Trial Profile
Association of disease activity and serum levels of golimumab in patients with spondiloarthritis: A SpA-Paz cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Spondylarthritis
- Focus Pharmacokinetics; Therapeutic Use
- 07 Jul 2017 New trial record
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism